Guillain-Barré syndrome (GBS) is an ascending paralysis. Weakness typically starts in the feet and legs, then climbs upward through the torso, arms, and potentially the face and breathing muscles. This bottom-to-top pattern is the hallmark that distinguishes GBS from other neurological emergencies, though a few rare variants break the rule.
How the Weakness Typically Spreads
The most common form of GBS begins with tingling and weakness in the feet. Within hours to days, that weakness moves up through the legs, into the trunk, and eventually into the arms. Some people first notice they’re having unexpected trouble climbing stairs or walking. The progression can be rapid, with symptoms worsening over hours, or more gradual over one to two weeks.
Weakness generally peaks within two to four weeks of the first symptoms. About 80% of adults are able to walk independently again within six months, and roughly 84% regain that ability within a year. Children tend to recover faster, with 90% walking independently by six months.
The ascending pattern matters because as weakness climbs higher, it can reach the muscles that control breathing. When that happens, patients need close monitoring in a hospital. Doctors track lung capacity measurements to decide whether someone needs a ventilator. Difficulty swallowing or speaking can also develop as the weakness reaches the face and throat, and these bulbar symptoms are one of the strongest predictors that breathing support will be needed.
Why It Starts in the Feet
GBS is an autoimmune condition. The immune system, usually after fighting off an infection, mistakenly attacks the peripheral nerves. In the most common form, immune cells target the protective myelin coating around nerves, slowing or blocking the electrical signals that control movement and sensation. The longest nerve fibers, which run from the spinal cord all the way down to the feet, appear to be the most vulnerable early on. That’s why symptoms show up in the extremities first and work their way inward and upward as the immune attack spreads to shorter nerve fibers closer to the spine.
Variants That Don’t Follow the Pattern
Not every case of GBS is textbook ascending paralysis. A few recognized variants progress differently, and knowing they exist helps explain why doctors sometimes struggle with early diagnosis.
Miller Fisher syndrome is the best-known exception. It accounts for a small percentage of GBS cases and presents with descending paralysis, starting with the eyes. The classic triad is double vision or difficulty moving the eyes, loss of coordination, and absent reflexes. Weakness can then spread downward to the arms and legs. This variant involves a specific immune response targeting nerve structures concentrated around the eye muscles and cranial nerves.
Pharyngeal-cervical-brachial variant is even rarer, making up about 3% of GBS cases. It begins with weakness in the throat, neck, and arms rather than the legs. Swallowing difficulty and a weak voice are early signs. This variant carries a higher risk of respiratory failure because the muscles involved in breathing are affected early in the course of illness, not late as in typical ascending GBS.
Some people with standard GBS also notice their first symptoms in the hands or face rather than the feet, even without having a named variant. These cases still generally follow a spreading pattern, but the starting point can vary.
GBS vs. Botulism: Ascending vs. Descending
The direction of paralysis is one of the key clinical clues that separates GBS from botulism, its most common look-alike. Botulism causes descending paralysis. It starts with the cranial nerves, producing drooping eyelids, blurred vision, slurred speech, and difficulty swallowing, then moves downward to the arms, trunk, and legs. GBS does the opposite. In a CDC review of 332 suspected botulism cases, GBS was the most frequently considered alternative diagnosis, appearing in nearly a third of cases where doctors were uncertain. The direction of spread is often what tips the diagnosis one way or the other.
Both conditions produce flaccid, symmetric weakness and can lead to respiratory failure. But the starting point tells the story. If weakness began in the legs and moved up, clinicians suspect GBS. If it started in the face and moved down, botulism jumps to the top of the list.
How GBS Is Confirmed
Diagnosis rests on a combination of clinical findings and lab work. The core features doctors look for are bilateral flaccid weakness in the limbs and decreased or absent deep tendon reflexes in the affected areas. Tapping your knee or ankle with a reflex hammer produces little or no response.
A spinal tap often reveals a characteristic pattern: elevated protein in the cerebrospinal fluid with a normal or near-normal white blood cell count. This combination, called albuminocytologic dissociation, shows up in the majority of GBS patients. In a large study of over 1,200 patients, 83% had completely normal cell counts below 5 cells per microliter, while protein levels were elevated above the normal threshold. Nerve conduction studies, which measure how fast electrical signals travel through peripheral nerves, provide additional confirmation by showing slowed or blocked signals consistent with nerve damage.
The full symptom course should follow a single-phase pattern lasting less than four weeks to peak severity. If weakness keeps worsening beyond that window or relapses after improvement, doctors consider chronic inflammatory demyelinating polyneuropathy, a related but distinct condition that requires different long-term management.